🇺🇸 FDA
Company

Agomab

Agomab Therapeutics NV

AGMB biotech USA

Quick answer

Agomab is a biotech company (AGMB) headquartered in ANTWERPEN, USA with 4 tracked pipeline programs.

Pipeline (4)

project

AGMB-129

Fibrostenotic Crohn's Disease

Phase 2 · small_molecule · active

2 trials project

AGMB-129

Healthy Volunteers

Phase 1 · small_molecule · completed

2 trials project

AGMB-447

IPF

Phase 1 · small_molecule · active

1 trials project

ORG-129

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials

Patents (4)

patent

US 12297186

Benzylamide derivatives as inhibitors of transforming growth factor-beta recepto

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084504

Anti-MET antibodies and uses thereof

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11834507

Anti-MET agonist antibody for use in the treatment of colorectal cancer

Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11098126

Anti-MET antibodies and uses thereof

Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)